Successful treatment of lupus with fludarabine

Lupus

Volumn 8, Issue 9, 1999, Pages 767-769

  Viallard, J F ^a   Mercie P ^a   Faure, I ^a   Pellegrin, J L ^a   Leng, B ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Chronic lymphocytic leukemia; Fludarabine; Systemic lupus erythematosus

Indexed keywords

FLUDARABINE; PREDNISONE; PURINE ANTAGONIST;

ADULT; ARTICLE; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; FEVER; HEART DILATATION; HERPES ZOSTER; HUMAN; INFECTIOUS COMPLICATION; LOBAR PNEUMONIA; MALE; MUSCLE STIFFNESS; POLYARTHRITIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032704697     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120399678840954     Document Type: Article

References (22)

1. Tallman MS, Hakimian D. Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders. Blood 1995; 86: 2463-2474.
2. Boldt DH, von Hoff DD, Kuhn JH, Hersh M. Effects on human peripheral lymphocytes of in vivo administration of 9-β-D-arabinofuranosyl-2-fluoroadenine-5′-monophosphate (NSC 312887), a new purine antimetabolite. Cancer Res 1984; 44: 4661-4666.
3. Evans TI, Nercessian BM, Sanders KM. Leukemic arthritis. Semin Arthritis Rheum 1994; 24: 48-56.
4. Weinberger A, Schumacher HR, Schimmer BM et al. Arthritis in acute leukemia. Clinical and histopathological observations. Arch Intern Med 1981; 141: 1183-1187.
5. Swissa M, Cohen Y, Shoenfeld Y. Autoantibodies in the sera of patients with lymphoma. Leuk Lymphoma 1992; 7: 117-122.
6. Dighiero G, Hart S, Lim A et al. Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas. Blood 1991; 78: 581-585.
7. Borche L, Lim A, Binet JL, Dighiero G. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood 1990; 76: 562-569.
8. Fort JG, Fernandez C, Jacobs SR, Abruzzo JL. B-cell surface marker analysis of synovial fluid cells in a patient with monoarthritis and chronic lymphocytic leukemia. J Rheumatol 1992; 19: 481-484.
9. Rudwaleit M, Elias F, Humaljoki T et al. Overexpanded B-cell clone mediating leukemic arthritis by abundant secretion of interleukin-1β. Arthritis Rheum 1998; 41: 1695-1701.
10. Lugassy G, Lishner M, Polliack A. Systemic lupus erythematosus and chronic lymphocytic leukemia. Rare coexistence in three patients with comment on pathogenesis. Leuk Lymphoma 1992; 8: 243-245.
11. Smith OP, Hoffbrand AV, Buckley C. Fludarabine and psoriasis. N Engl J Med 1994; 330: 1540-1541.
12. Davis JC Jr, Fessler BJ, Tassiulas IO et al. High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis. J Rheumatol 1998; 25: 1694-1704.
13. Priebe T, Platsoucas CD, Seki H et al. Purine nucleoside modulation of functions of human lymphocytes. Cell Immunol 1990; 129: 321-328.
14. Cheson B. Infections and immunosuppressive complications of purine analogue therapy. J Clin Oncol 1995; 13: 2431-2448.
15. Anaissie EJ, Kontoyiannis DP, O'Brien S et al. Infections in patients with chronic lymphocytic leukemia treated with Fludarabine. Ann Intern Med 1998; 129: 559-566.
16. Robertson LE, O'Brien S, Kantarjian H et al. A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia. Leukemia 1995; 9: 1444-1449.
17. Cortes JE, O'Brien SM. Defining the optimal dose schedule of purine analogs and assessment of response. In: Cheson BD, Keating MJ, Plunkett W (eds.) Nucleoside Analogs in Cancer Therapy New York: Marcel Dekker 1997 pp 175-199.
18. Beutler E, Sipe J, Romine J, McMillan R, Zyroff J, Koziol J. Treatment of multiple sclerosis and other autoimmune diseases with cladribine. Semin Hematol 1996; 33: 45-52.
19. Eibschutz B, Baird SM, Weisman MH et al. Oral 2-chlorodeoxyadenosine in psoriatic arthritis. Arthritis Rheum 1995; 38: 1604-1609.
20. Sipe JC, Romine JS, Koziol JA et al. Cladribine in treatment of chronic progressive multiple sclerosis. Lancet 1994; 344: 9-13.
21. Beutler E, Sipe J, Romine JS et al. The treatment of chronic progressive multiple sclerosis with cladribine. Proc Natl Acad Sci USA 1996; 93: 1716-1720.
22. Davis JC Jr, Austin H, Boumpas D et al. A pilot study of 2-chloro-2′-deoxyadenosine in the treatment of systemic lupus erythematosus glomerulonephritis. Arthritis Rheum 1998; 41: 335-343.